APPLICATIONS OF PHARMACOGENETICS TO DRUG DEVELOPMENT: THE GLAXO WELLCOME EXPERIENCE^*

TERESA ARLEDGE Glaxo Wellcome, Inc., 5 Moore Drive, P.O. Box 13398, Research Triangle ParkNorth Carolina, 27709-3398, U.S.A.

ANDREW FREEMAN Glaxo Wellcome, Inc., 5 Moore Drive, P.O. Box 13398, Research Triangle ParkNorth Carolina, 27709-3398, U.S.A.

JULIAN ARBUCKLE Glaxo Wellcome, Inc., 5 Moore Drive, P.O. Box 13398, Research Triangle ParkNorth Carolina, 27709-3398, U.S.A.

MICHAEL MOSTELLER Glaxo Wellcome, Inc., 5 Moore Drive, P.O. Box 13398, Research Triangle ParkNorth Carolina, 27709-3398, U.S.A.

PENELOPE MANASCO Glaxo Wellcome, Inc., 5 Moore Drive, P.O. Box 13398, Research Triangle ParkNorth Carolina, 27709-3398, U.S.A.

REFERENCES

Anderson W. H., Fitzgerald C. Q., Manasco P. K. Current and future applications of pharmacogenomics. New Horizons 1999; 7(2)262–269
Google Scholar
Wang D. G., Fan J. B., Siao C. J., Berno A., Young P., Sapolsky R., et al. Large-scale identification, mapping and genotyping of single-nucleotidepolymorphisms in the human genome. Science 1998; 280: 1077–1082
PubMed Web of Science ®Google Scholar
Marshall E. Drug firms to create public database of genetic mutations. Science 1999; 284: 406–407
PubMed Web of Science ®Google Scholar
Evans W. E., Relling M. V. Pharmacogenomics: Translating functional genomics into rationaltherapeutics. Science 1999; 286: 487–491
PubMed Web of Science ®Google Scholar
Elston R. Linkage and association. Genet. Epidemiol. 1998; 15: 565–576
PubMed Web of Science ®Google Scholar
Lai E., Riley J., Purvis I., Roses A. A 4-Mb high-density single nucleotide polymorphism-based maparound human APOE. Genomics 1998; 54: 31–38
PubMed Web of Science ®Google Scholar
Reilly P. R., Boshar M. F., Holtzman S. H. Ethical issues in genetic research: Disclosure and informedconsent. Nature Genet. 1997; 15: 16–20
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

APPLICATIONS OF PHARMACOGENETICS TO DRUG DEVELOPMENT: THE GLAXO WELLCOME EXPERIENCE^*

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

APPLICATIONS OF PHARMACOGENETICS TO DRUG DEVELOPMENT: THE GLAXO WELLCOME EXPERIENCE*

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

APPLICATIONS OF PHARMACOGENETICS TO DRUG DEVELOPMENT: THE GLAXO WELLCOME EXPERIENCE^*